Contact Information
Company Information
Company
Candid Therapeutics
Professional Summary
Ken Song serves as President and CEO, Chairman of the Board at Candid Therapeutics at Candid Therapeutics. Candid Therapeutics operates in the research sector with approximately 36.0 employees. The company is headquartered in San Diego, California.
Industry & Role Insights
-
•
MessageCEO tracks 2,961 executives in the research sector.
-
•
We have verified contacts for 2 executives at Candid Therapeutics.
-
•
13,743 executive contacts are available in California.
-
•
Our database includes 201,469 c suite-level executives.
Technologies
Outlook
Microsoft Office 365
Zendesk
Keywords
biotechnology
drug development
therapeutics
biotechnology research
autoimmune diseases
t-cell engagers
bispecific antibodies
immunotherapy
b-cell depletion
novel therapies
clinical development
research & development
fda approval
therapy pipeline
biopharmaceuticals
immune response
molecular biology
clinical trials
targeted therapy
transformative efficacy
precision medicine
therapeutic innovation
drug candidate
patient benefit
clinical outcomes
regulatory compliance
therapeutic area management
novel drug delivery
clinical operations
drug formulation
research collaboration
high throughput screening
immunological mechanisms
innovative biotech
cancer therapy
medical research
drug efficacy
patient-centered care
investment in biopharma
stakeholder value
biotherapeutics
therapy optimization
advanced drug design
biologics manufacturing
clinical research organization
therapeutic approvals
immunological therapies
biotech investment
patient trials
scientific validation
disease modification
therapeutic strategy
health care
health
wellness & fitness
hospital & health care
Related Executives
Outreach Guidance — research Sector
Executives like Ken Song in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Candid Therapeutics.
Ken Song's Position in the MessageCEO Database
- •Ken Song is 1 of 2 verified executive contacts we track at Candid Therapeutics.
- •2,871 verified executive contacts in research are in the MessageCEO database.
- •12,901 verified executive contacts in California are in the database.
- •34 verified contacts work at research companies in the 36.0 employee range (same size as Candid Therapeutics).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.
Frequently Asked Questions
How do I reach Ken Song directly?
Ken Song's verified email address is available to MessageCEO Pro subscribers. They currently serve as President and CEO, Chairman of the Board at Candid Therapeutics at Candid Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Ken Song work for?
Ken Song is President and CEO, Chairman of the Board at Candid Therapeutics at Candid Therapeutics, a company in the research sector with 36.0 employees. The company is based in San Diego, California.
Can I pitch or sell to Ken Song?
As President and CEO, Chairman of the Board at Candid Therapeutics at Candid Therapeutics, Ken Song is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Ken Song directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Ken Song in?
Ken Song works in the research industry as President and CEO, Chairman of the Board at Candid Therapeutics at Candid Therapeutics. MessageCEO provides verified contact information for executives across all major industries.
Is Ken Song's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Ken Song's profile is kept up-to-date with the latest available information.
Last updated: July 22, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans